Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SILDENAFIL CITRATE USP, with a corresponding US DMF Number 19097.
Remarkably, this DMF maintains an Active status since its submission on January 10, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 20, 2025, and payment made on October 14, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II